Literature DB >> 20584222

Evaluation of NT-proBNP to predict outcomes in advanced heart failure.

G A MacGowan1, D Neely, R Peaston, N Wrightson, G Parry.   

Abstract

AIMS: To determine which factors predict outcomes in a group of patients with advanced heart failure, and in particular if NT-proBNP provides additional clinical and prognostic information to other haemodynamic and biochemical data. METHODS AND
RESULTS: Ninety-one patients were studied who were being evaluated for heart transplantation, with 166 assessments. The patients had advanced heart failure as determined by median cardiac index of 2.0 l/min/m(2), left ventricular end-diastolic diameter of 7.0 mm and levels of NT-proBNP of 2473 pg/ml. Median follow-up time was 359 days. Clinicians were blinded to NT-proBNP levels. NT-proBNP significantly correlated with cardiac index (R = -0.44, p < 0.001), right atrial pressure (R = 0.40, p < 0.001), pulmonary arterial wedge pressure (R = 0.38, p < 0.001) and albumin (R = -0.52, p < 0.001), and total bilirubin with right atrial pressure (R = 0.59, p < 0.001). Cardiac index was the most important independent predictor of outcome (p = 0.0001), although bilirubin (p = 0.001) and NT-proBNP (p < 0.05) were also significant. In patients with a 50% increase in NT-proBNP, 64% had adverse outcomes, whereas those in whom levels were stable, 22% had adverse outcomes (p < 0.05).
CONCLUSION: Cardiac index is the primary independent predictor of outcome in advanced heart failure when haemodynamic deterioration is evident. In situations where invasive haemodynamics are not available, total bilirubin (reflecting hepatic congestion) and NT-proBNP (related to haemodynamics) also provide important prognostic information.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584222     DOI: 10.1111/j.1742-1241.2010.02388.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

Review 1.  BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.

Authors:  Mark Oremus; Andrew Don-Wauchope; Robert McKelvie; Pasqualina L Santaguida; Stephen Hill; Cynthia Balion; Ronald Booth; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure.

Authors:  Wioletta Szczurek-Wasilewicz; Michał Skrzypek; Ewa Romuk; Mariusz Gąsior; Bożena Szyguła-Jurkiewicz
Journal:  J Clin Med       Date:  2022-05-04       Impact factor: 4.964

Review 3.  Aortic Pulsatility Index: A New Haemodynamic Measure with Prognostic Value in Advanced Heart Failure.

Authors:  Tania Deis; Kasper Rossing; Finn Gustafsson
Journal:  Card Fail Rev       Date:  2022-05-16

4.  Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease.

Authors:  Marc Lapointe; Paul Poirier; Julie Martin; Marjorie Bastien; Audrey Auclair; Katherine Cianflone
Journal:  Cardiovasc Diabetol       Date:  2014-08-21       Impact factor: 9.951

5.  Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis.

Authors:  Selina J Hein; Maximilian Knoll; Fabian Aus dem Siepen; Jennifer Furkel; Stefan Schoenland; Ute Hegenbart; Hugo A Katus; Arnt V Kristen; Mathias Konstandin
Journal:  World J Cardiol       Date:  2021-03-26

6.  Differential expression of B-type natriuretic peptide between left and right ventricles, with particular regard to sudden cardiac death.

Authors:  Zhi-Peng Cao; Jia-Jia Xue; Yuan Zhang; Mei-Hui Tian; Ying Xiao; Yu-Qing Jia; Bao-Li Zhu
Journal:  Mol Med Rep       Date:  2017-08-02       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.